Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exon-Skipping in Duchenne Muscular Dystrophy
Shin’ichi Takeda, Paula R. Clemens, Eric P. Hoffman
Journal of Neuromuscular Diseases (2021) Vol. 8, Iss. s2, pp. S343-S358
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Control of satellite cell function in muscle regeneration and its disruption in ageing
Pedro Sousa‐Victor, Laura García‐Prat, Pura Muñoz‐Cánoves
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 3, pp. 204-226
Closed Access | Times Cited: 288
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Addeli Bez Batti Angulski, Nora Hosny, Houda Cohen, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 71
Mismatch prime editing gRNA increased efficiency and reduced indels
Jidong Fei, Dongdong Zhao, Chong‐Jin Pang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Perspectives of Rare Disease Experts on Newborn Genome Sequencing
Nina B. Gold, Sophia Adelson, Nidhi Shah, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2312231-e2312231
Open Access | Times Cited: 34
Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy
Emanuela Viggiano, Esther Picillo, Luigia Passamano, et al.
Genes (2023) Vol. 14, Iss. 1, pp. 214-214
Open Access | Times Cited: 18
Disrupted Calcium Homeostasis in Duchenne Muscular Dystrophy: A Common Mechanism behind Diverse Consequences
Barbara Zabłocka, Dariusz C. Górecki, Krzysztof Zabłocki
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11040-11040
Open Access | Times Cited: 39
Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy
Gökçe Eser, Haluk Topaloğlu
Genes (2022) Vol. 13, Iss. 7, pp. 1241-1241
Open Access | Times Cited: 26
Exome Sequencing and Optical Genome Mapping in Molecularly Unsolved Cases of Duchenne Muscular Dystrophy: Identification of a Causative X-Chromosomal Inversion Disrupting the DMD Gene
Leoni S. Erbe, Sabine Hoffjan, Sören Janßen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14716-14716
Open Access | Times Cited: 13
Immune-mediated myositis following gene therapy for Duchenne muscular dystrophy: a case report
Susan T. Iannaccone, Chunyu Cai, Brittney Rhem, et al.
Journal of Neurology (2024) Vol. 271, Iss. 8, pp. 5659-5664
Open Access | Times Cited: 4
CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives
Guofang Chen, Tingyi Wei, Hui Yang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2964-2964
Open Access | Times Cited: 17
Nephrotoxicity of marketed antisense oligonucleotide drugs
Hangyu Wu, Aniket Wahane, Feryal Alhamadani, et al.
Current Opinion in Toxicology (2022) Vol. 32, pp. 100373-100373
Open Access | Times Cited: 17
Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skipping
Made Harumi Padmaswari, Shilpi Agrawal, Christopher E. Nelson
Journal of Neuromuscular Diseases (2025)
Closed Access
CRISPR-Cas9 homology-independent targeted integration of exons 1–19 restores full-length dystrophin in mice
Anthony A. Stephenson, Stefan Nicolau, Tatyana A. Vetter, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 30, pp. 486-499
Open Access | Times Cited: 9
Benfotiamine improves dystrophic pathology and exercise capacity in mdx mice by reducing inflammation and fibrosis
Chantal A. Coles, Keryn G. Woodman, Elizabeth M. Gibbs, et al.
Human Molecular Genetics (2024) Vol. 33, Iss. 15, pp. 1339-1355
Open Access | Times Cited: 3
Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration
Katarzyna Budzynska, Maria Siemionow, Katarzyna Stawarz, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 575-575
Open Access | Times Cited: 3
Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy
Lakshmi Krishna, Akila Prashant, Yogish H. Kumar, et al.
Neurology International (2024) Vol. 16, Iss. 4, pp. 731-760
Open Access | Times Cited: 3
Development of orphan drugs for rare diseases
Han‐Wook Yoo
Clinical and Experimental Pediatrics (2023) Vol. 67, Iss. 7, pp. 315-327
Open Access | Times Cited: 8
Molecular mechanisms and therapeutic strategies for neuromuscular diseases
Alberto A. Zambon, Falzone Yuri Matteo, Bolino Alessandra, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Cyclo His‐Pro Attenuates Muscle Degeneration in Murine Myopathy Models
Alessia De Masi, Nadège Zanou, Keno Strotjohann, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 2
Titin-related Cardiomyopathy: Is it a Distinct Disease?
Celine Santiago, Inken G. Huttner, Diane Fatkin
Current Cardiology Reports (2022) Vol. 24, Iss. 9, pp. 1069-1075
Closed Access | Times Cited: 9
Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy
Jiexin Deng, Fangli Liu, Zhifen Feng, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 5, pp. 891-903
Open Access | Times Cited: 1
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment
Marika Faiella, Giada Botti, Alessandro Dalpiaz, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1023-1023
Open Access | Times Cited: 1
Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
Maria Luisa Bianchi, Silvia Vai, Giovanni Baranello, et al.
JBMR Plus (2022) Vol. 6, Iss. 11
Open Access | Times Cited: 6
Higher Prevalence of Nonsense Pathogenic DMD Variants in a Single-Center Cohort from Brazil: A Genetic Profile Study That May Guide the Choice of Disease-Modifying Treatments
Vitor Lucas Lopes Braga, Danielle Pessoa Lima, Tamiris Carneiro Mariano, et al.
Brain Sciences (2023) Vol. 13, Iss. 11, pp. 1521-1521
Open Access | Times Cited: 3
Specificities of the DMD Gene Mutation Spectrum in Russian Patients
Elena Zinina, Maria Bulakh, А. Л. Чухрова, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12710-12710
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top